Detalles de la búsqueda
1.
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer.
Curr Oncol Rep
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38639793
2.
Aneuploidy rates and morphokinetic parameters of embryos cultured in distinct culture media: a sibling oocyte study.
Hum Reprod
; 37(2): 226-234, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34791277
3.
Microfluidic preparation of spermatozoa for ICSI produces similar embryo quality to density-gradient centrifugation: a pragmatic, randomized controlled trial.
Hum Reprod
; 37(7): 1406-1413, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35522187
4.
Hormone concentrations of dominant follicles in the TALES randomized controlled trial comparing letrozole with tamoxifen.
J Assist Reprod Genet
; 39(11): 2617-2624, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36192617
5.
Fertility preservation practices for female oncofertility differ significantly across the USA: results of a survey of SREI members.
J Assist Reprod Genet
; 39(8): 1749-1757, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35870098
6.
Breast cancer grade and stage do not affect fertility preservation outcomes.
J Assist Reprod Genet
; 39(5): 1155-1161, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320444
7.
Regional air transportation of ovarian tissue for cryopreservation in a prepubertal female with cancer.
Pediatr Blood Cancer
; 68(9): e29107, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105898
8.
Conception after chemotherapy: post-chemotherapy method of conception and pregnancy outcomes in breast cancer patients.
J Assist Reprod Genet
; 38(7): 1755-1765, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740176
9.
Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
J Assist Reprod Genet
; 38(9): 2455-2463, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312774
10.
Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial.
JAMA
; 326(5): 390-400, 2021 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34342619
11.
Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Cancer
; 126(3): 487-495, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31639215
12.
Perceptions, motivations and decision regret surrounding preimplantation genetic testing for aneuploidy.
Hum Reprod
; 35(9): 2047-2057, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32756971
13.
Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
J Assist Reprod Genet
; 36(6): 1161-1168, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31127475
14.
Microfluidic sorting selects sperm for clinical use with reduced DNA damage compared to density gradient centrifugation with swim-up in split semen samples.
Hum Reprod
; 33(8): 1388-1393, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30007319
15.
Decreased clinical pregnancy and live birth rates after short interval from delivery to subsequent assisted reproductive treatment cycle.
Hum Reprod
; 33(7): 1316-1321, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29912323
16.
Allostatic load, a measure of chronic physiological stress, is associated with pregnancy outcomes, but not fertility, among women with unexplained infertility.
Hum Reprod
; 33(9): 1757-1766, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30085177
17.
Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit.
J Assist Reprod Genet
; 35(12): 2155-2159, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30334131
18.
Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
J Assist Reprod Genet
; 35(2): 309, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29178020
19.
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
J Assist Reprod Genet
; 35(2): 297-307, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29086322
20.
Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
J Assist Reprod Genet
; 35(10): 1861-1868, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30066303